G. Zernig et N. Reider, ION DEPENDENCE OF THE PARTIALLY PURIFIED MITOCHONDRIAL DIHYDROPYRIDINE CA2+ ANTAGONIST RECEPTOR, Molecular pharmacology, 41(1), 1992, pp. 45-52
The mitochondrial inner membrane contains specific binding sites for d
ihydropyridine (DHP) Ca2+ antagonists that are associated with an inne
r mitochondrial membrane anion channel (IMAC) [Mol. Pharmacol. 38:362-
369 (1990)]. As in particulate preparations, binding of the DHP (+/-)-
[H-3]nitrendipine ([H-3]NTR) to partially purified mitochondrial DHP r
eceptors strongly depended on a variety of cations and inorganic as we
ll as organic anions. Monovalent anions saturably stimulated [H-3]NTR
binding with a potency rank order of 1- > Br- > Cl- > F-. The potency
rank order for monovalent cations was Cs+ > Rb+ > Li+ > K+ > Na+. [H-3
]NTR binding stimulation potency of the cations strikingly depended on
their charge density, with EC50 values being 125 mM for K+, 5 mM for
Ca2+, and 41-mu-M for La3+. This selectivity order clearly differed fr
om one predicted on the basis of a simple surface charge-screening eff
ect of the cations. In general, allosteric ion effects were due to cha
nges in [H-3]NTR affinity for the partially purified mitochondrial DHP
receptor. SCN- and NO3-, known permeators of the IMAC [J. Biol. Chem.
262: 15085-15093 (1987)], stimulated [H-3]NTR binding with EC50 value
s of 26 mM and 96 mM, respectively. The IMAC permeators butylmalonate2
- and 1,2,3-benzenetricarboxylate3- were ineffective when given alone
but dose-dependently inhibited 500 mM NaCl-stimulated [H-3]NTR binding
, as did PO4(1.5-) and SO4(2-). Gluconate-, which was reported not to
permeate the IMAC, qualitatively behaved as a partial agonist with res
pect to Cl-. Glucuronate- was without effect on [H-3]NTR binding to th
e partially purified mitochondrial DHP receptor. These results point t
o the existence of rather large ion-binding domains. The cation-bindin
g site was estimated to have a minimum diameter of 0.67 nm. The anion-
binding domain could accommodate either spherical ligands with diamete
rs of up to 0.6 nm or molecules with a flat backbone with dimensions o
f approximately 0.9 nm x 0.7 nm x 0.3 nm.